ScholarIQanswers from OpenAlex & ORCID
Andrew L. Kung
ResearcherPublications, citations & collaboration network
Andrew L. Kung is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andrew L. Kung have?
ScholarIQindexed works
Andrew L. Kung has 956 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrew L. Kung have?
ScholarIQcitation count
Andrew L. Kung has 48,824 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andrew L. Kung?
ScholarIQh-index
Andrew L. Kung has an h-index of 106 in OpenAlex.
What is the i10-index of Andrew L. Kung?
ScholarIQi10-index
Andrew L. Kung has an i10-index of 249 in OpenAlex.
What is the ORCID of Andrew L. Kung?
ScholarIQorcid
The ORCID for Andrew L. Kung is on the source record.
What is the OpenAlex record for Andrew L. Kung?
ScholarIQopenalex
The OpenAlex for Andrew L. Kung is on the source record.
What are the most-cited papers on Andrew L. Kung?
ScholarIQmost cited works
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt, Nan Zhu, Amit Sinha, Sridhar Vempati, Joerg Faber, Andrei V. Krivtsov, Zhaohui Feng, Natalie Punt, Amanda J. Daigle, Lars Bullinger, Roy M. Pollock, Victoria M. Richon, Andrew L. Kung, Scott A. Armstrong
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka, Shavali Shaik, Ichiro Onoyama, Daming Gao, Alan Tseng, Richard S. Maser, Bo Zhai, Lixin Wan, Alejandro Gutiérrez, Alan W. Lau, Yonghong Xiao, Amanda L. Christie, Jon C. Aster, Jeffrey Settleman, Steven P. Gygi, Andrew L. Kung, Thomas Look, Keiichi I. Nakayama, Ronald A. DePinho, Wenyi Wei
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Joshua B. Rubin, Andrew L. Kung, Robyn S. Klein, Jennifer A. Chan, Yanping Sun, Karl Schmidt, Mark W. Kieran, Andrew D. Luster, Rosalind A. Segal
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Chen Zhao, Katherine A. Cheng, Zandra E. Walton, Yuchuan Wang, Hiromichi Ebi, Takeshi Shimamura, Yan Liu, Tanya Tupper, Jing Ouyang, Jie Li, Peng Gao, Michele Sue‐Ann Woo, Chunxiao Xu, Masahiko Yanagita, Abigail Altabef, Shumei Wang, Charles Lee, Yuji Nakada, Christopher G. Peña, Yanping Sun, Yoko Franchetti, Catherine Yao, Amy Saur, Michael D. Cameron, Mizuki Nishino, D. Neil Hayes, Matthew D. Wilkerson, Patrick J. Roberts, Carrie B. Lee, Nabeel Bardeesy, Mohit Butaney, Lucian R. Chirieac, Daniel B. Costa, David M. Jackman, Norman E. Sharpless, Diego H. Castrillón, George D. Demetri, Pasi A. Jänne, Pier Paolo Pandolfi, Lewis C. Cantley, Andrew L. Kung, Jeffrey A. Engelman, Kwok‐Kin Wong
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
Xiaobo Xia, Madeleine E. Lemieux, Wěi Li, Jason S. Carroll, Myles Brown, X. Shirley Liu, Andrew L. Kung